Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway.
Pharmaceuticals (Basel, Switzerland)
Wang X, Shao G, Hong X, Shi Y, Zheng Y, Yu Y, Fu C.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2023
Cancer Research
No items found.
Key Finding
The study demonstrated that annexin A1 (ANXA1) was overexpressed in tumors of 50% of colon cancer patients, and ANXA1 overexpression was significantly negatively correlated with the poor prognosis of colon cancer.
Countstar Connection
The researchers assessed cell numbers in the study's cell samples with Countstar (model not specified) during the study's growth assessment.
